Login
$AVAH
$12.70 -$0.48 (3.64%) Close

Company Executives

$AVAH Management Team

Mr. Jeffrey Shaner

President

Chief Executive Officer

Director

Age 52
Compensation $4.543M USD
Sex Male

Ms. Deborah Stewart

Senior Vice President

Chief Accounting Officer

Age 41
Compensation -
Sex Female

Mr. Ed Reisz

Chief Administrative Officer

Age 66
Compensation $1.872M USD
Sex Male

Mr. Patrick Cunningham

Chief Compliance Officer

Age 69
Compensation -
Sex Male

Mr. Rodney Windley

Non-Executive Chairman of the Board

Age 77
Compensation $252.0K USD
Sex Male

Mr. Jerry Perchik

Chief Legal Officer

Secretary

Age 67
Compensation $2.402M USD
Sex Male

Mr. Matthew Buckhalter

Chief Financial Officer

Age 36
Compensation $1.703M USD
Sex Male
Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
6.3 years
from year joined
CEO also chairs the board
No
Rodney D. Windley
Director Age On board Independent Committees Other public boards 2025 pay Source
Rodney D. Windley
Not stated 2017
9 years
Independent None stated None stated $252,000
Sam Weil
Not stated 2025
1 year
Independent
Compensation Committee
None stated Not stated
Steven E. Rodgers
Not stated 2017
9 years
Independent
Audit Committee
None stated $220,000
Victor F. Ganzi
Not stated Not stated Independent None stated None stated $225,000
Brent Layton
Not stated Not stated Independent
Audit Committee
None stated $212,500
Devin O’Reilly
Not stated Not stated Independent None stated None stated Not stated
Erica Schwartz
Not stated Not stated Independent None stated None stated $212,000
Jeff Shaner
Not stated Not stated Not independent
Clinical Quality Committee
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

4 disclosed in the proxy filed Apr 17, 2026
Steven E. Rodgers
Designated by J.H. Whitney Capital Partners under the A&R Stockholders Agreement
Amount not stated

Director designated by J.H. Whitney Capital Partners under the A&R Stockholders Agreement.

With J.H. Whitney Capital Partners Open in proxy
Devin O’Reilly and Sam Weil
Designated by Bain Capital under the A&R Stockholders Agreement
Amount not stated

Directors designated by Bain Capital under the A&R Stockholders Agreement.

With Bain Capital Open in proxy
Certain selling stockholders affiliated with J.H. Whitney Capital Partners
Affiliated with J.H. Whitney Capital Partners
Amount not stated
2025

Selling stockholders affiliated with J.H. Whitney Capital Partners sold 10,000,000 shares of common stock in an underwritten offering, and later sold an additional 1,500,000 shares after full exercise of an over-allotment option.

With The Company (underwritten offering of common stock) Open in proxy
Affiliates of Bain Capital
Affiliates of Bain Capital, one of our Sponsors, held a controlling interest prior to October 2019 and currently hold a minority position
Approximately $0.4 million
fiscal year ended January 3, 2026

Subsidiaries paid Waystar under software agreements for payment processing, patient claim management and denial and appeal management.

With ZirMed, Inc. d/b/a Waystar Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support